BioSpace News Archive

Biotech Beach

VCA Releases First Ever Social Impact Report

Report Demonstrates Excellence in Healthcare and Commitment to Animal Welfare

April 30, 2019
·
3 min read
Deals

BiondVax Announces Fourth Quarter and Full Year 2018 Financial Results and Update

BiondVax Pharmaceuticals Ltd. announced its fourth quarter and full year financial results for the year ended December 31, 2018 and provided a business update.

April 30, 2019
·
7 min read
Business

CryoLife Reports First Quarter 2019 Financial Results

Net loss was ($297,000), or ($0.01) per fully diluted common share; non-GAAP net income was $1.5 million, or $0.04 per fully diluted common share

April 30, 2019
·
6 min read
Deals

Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2019 on May 7, 2019

Array BioPharma Inc. will report financial results for the third quarter of fiscal 2019 and hold a conference call to discuss those results on Tuesday, May 7, 2019 at 9:00 am ET.

April 30, 2019
·
1 min read
Genetown

Alnylam Highlights Progress on Global Market Access for ONPATTRO (patisiran)

In the United States, Company Completes Tenth Value-Based Agreement with Commercial Payers, and Achieves Confirmed Access to ONPATTRO for Greater than 90 Percent of Covered Lives

April 30, 2019
·
10 min read
Deals

Tandem Diabetes Care Announces First Quarter 2019 Financial Results and Updated 2019 Financial Guidance

Tandem Diabetes Care, Inc. reported its financial results for the quarter ended March 31, 2019 and updated its financial guidance for the year ending December 31, 2019.

April 30, 2019
·
9 min read
Deals

OSI Systems Reports Third Quarter Fiscal 2019 Financial Results

OSI Systems, Inc. announced financial results for the three and nine months ended March 31, 2019.

April 30, 2019
·
15 min read
Deals

Quidel to Hold First Quarter 2019 Financial Results Conference Call on May 8th, 2019

Quidel Corporation will report first quarter 2019 financial results after market close on Wednesday, May 8, 2019.

April 30, 2019
·
2 min read
Business

RMS Medical Products Announces 2019 First Quarter Financial Results

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical”) today announced financial results for the three months ended March 31, 2019 (“Q1 2019”).

April 30, 2019
·
11 min read
Deals

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetIQ, Inc. - PETQ

Pomerantz LLP is investigating claims on behalf of investors of PetIQ, Inc..

April 30, 2019
·
1 min read